Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

Clinical trial NCT00792298 · COMPLETED

Trial details

NCT number: NCT00792298
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Insomnia

Start date: 2008-11-05
Primary completion: 2009-12-26
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.